Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Omega vs Epoetin Beta in Hemodialyzed Patients with Anemia Hyporesponsive to Epoetin Beta
2004-000673-57Phase 2Completed
- Sponsor
- Baxter
- Start
- Oct 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised trial of epoetin omega in anaemia (2 arms), sponsored by Baxter. Primary endpoint: Primary efficacy variables. Started Oct 2004; status: completed.
02
Drugs
epoetin omega
03
Conditions
anaemia
Beyond the preview
Go deeper on 2004-000673-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000673-57.